Phase-II-Study with EAP (Etoposide, Adriamycin, Cis- Platinum) in Patients with Primary Inoperable Gastric Cancer and Advanced Disease
Authors:
- 1 January 1988
- book chapter
- Published by Springer Nature
- Vol. 110, 198-206
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Controlled Phase III Clinical Study of 4-Epi-Doxorubicin + 5-Fluorouracil versus 5-Fluorouracil Alone in Metastatic Gastric and Rectosigmoid CancerOncology, 1986
- Cis-Diaminodichloroplatinum (II) Chemotherapy for Advanced Adenocarcinoma of the Upper Gastrointestinal TractOncology, 1985
- Defective neutrophil mobilization to skin chambers in cancer patientsJournal of Cancer Research and Clinical Oncology, 1984
- A phase II study of cisplatin in advanced gastric cancerEuropean Journal of Cancer and Clinical Oncology, 1983
- Model studies of etoposide resistanceCancer Treatment Reviews, 1982
- Etoposide—chemistry, preclinical and clinical pharmacologyCancer Treatment Reviews, 1982
- An effective low-dose adriamycin regimen as secondary chemotherapy for metastatic breast cancer patientsCancer, 1980
- Cis‐platinum therapy of previously treated head and neck cancer: The Southwest Oncology Group's two‐dose‐per‐month outpatient regimenMedical and Pediatric Oncology, 1980
- Improved combination chemotherapy in advanced gastric cancer.BMJ, 1979
- Mitomycin C: Experience in the United States, with emphasis on gastric cancerCancer Chemotherapy and Pharmacology, 1978